¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Genes, Tumor Suppressor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Wilms¡¯ tumor
    ºô¸§½ºÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • tumor stain
    Á¾¾çÁ¶¿µ
  • tumor cell survival
    Á¾¾ç¼¼Æ÷»ýÁ¸
  • tumor
    Á¾¾ç
  • teratodermoid tumor
    ±âÇüÀ¯ÇÇÁ¾
  • teratoid tumor
    ±âÇüÁ¾
  • tridermic tumor
    »ï¹è¿±Á¾¾ç
  • trophoblastic tumor
    ¿µ¾ç¸·Á¾¾ç
  • virilizing tumor
    ³²¼ºÈ­Á¾¾ç
  • virus-induced tumor
    ¹ÙÀÌ·¯½ºÀ¯¹ßÁ¾¾ç
  • Wilms' tumor
    Àª¸§ÁîÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ranine tumor =ranulus
    µÎ²¨ºñÁ¾¾ç(¡­ðþåË). µÎ²¨ºñÁ¾(¡­ðþ), Çϸ¶Á¾(ùÁØ©ðþ)
  • recurrent tumor
    Àç¹ß¼º Á¾¾ç(î¢Û¡àõðþåË)
  • renal pelvic tumor
    ½Å¿ìÁ¾¾ç
  • renal pelvic tumor
    ½Å¿ìÁ¾¾ç(ãìéâðþåË)
  • renin-secreting juxtaglomerular tumor
    ·¹´ÑºÐºñ¼º¹æ»ç±¸Ã¼Á¾¾ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • blood tumor
    Ç÷¾×Á¾¾ç.
  • bone tumor
    °ñ Á¾¾ç(ÍéðþåË).
  • brain stem tumor
    ³ú°£Á¾¾ç(ÒàÊÏðþåË).
  • breast tumor
    À¯¹æÁ¾¾ç(À¯¹æÁ¾¾ç).
  • brenner tumor
    ºê·¹³Ê¾¾ Á¾¾ç
  • brenner tumor
    ºê·»³Ê Á¾¾ç (¡­ðþåË)
  • bronchial tumor
    ±â°üÁöÁ¾¾ç(¡­ðþåË).
  • bronchioloalveolar tumor
    ¼¼±â°üÁö ÆóÆ÷¼º Á¾¾ç(¡­øËøààõðþåË)
  • brown tumor
    °¥»öÁ¾¾ç(¡­ðþåË)
  • brown tumor, hyperparathyroidism
    °¥»öÁ¾¾ç, ºÎ°©»ó¼±±â´É Ç×ÁøÁõ(ÜùË£ßÒàÍѦÒö ùñòäñø)
  • buschke(lowenstein)tumor
    ºÎ½¬ÄÉ(·ÎÀ¢½ºÅ¸ÀÎ) Á¾¾ç(¡­ðþåË)
  • carcinoid tumor
    Ä«¸£½Ã³ëÀ̵åÁ¾¾ç
  • carcinoid tumor
    Ä«¸£½Ã³ëÀ̵åÁ¾¾ç(¡­Á¾¾ç).
  • carcinoid tumor
    Ä«¸£½Ã³ëÀ̵åÁ¾¾ç(¡­ðþåË)
  • cardiac tumor
    ½ÉÀåÁ¾¾ç(ãýíôðþåË)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
IDEM tumor Intra-Dural Extra-Medullary tumor
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
GCT general care and treatment; germ-cell tumor; giant cell thyroiditis; giant cell tumor
ICT icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int...
JGCT juvenile granulosa cell tumor; juxtaglomerular cell tumor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SOCS3 suppressor of cytokine signalling 3
Su(f) Suppressor of forked
Spm Suppressor-mutator
Tc/s T , cytotoxic/suppressor T
Ts T "suppressor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • monogerminal mixed tumor
    ´Ü ¹è¿±¼º È¥ÇÕ Á¾¾ç
  • mucoepidermoid tumor
    Á¡¸· À¯Ç¥ÇÇ ¾Ï, Á¡¾× Ç¥ÇǾç Á¾¾ç
  • mucosal-colored tumor
    Á¡¸·»ö Á¾¾ç
  • mucous tumor
    Á¡¾×Á¾
  • multiple vascular tumor
    ´Ù¹ß¼º Ç÷°ü Á¾¾ç
  • nasopharyngeal tumor
    ºñ ÀεΠÁ¾¾ç
  • nerve tumor
    ½Å°æ Á¾¾ç
  • neuroectodermal tumor
    ½Å°æ ¿Ü¹è¿± Á¾¾ç
  • neuroendocrine tumor
    ½Å°æ ³»ºÐºñÁ¾
  • neuroglial tumor
    ½Å°æ±³ Á¾¾ç
  • nevoid tumor
    ¸ð¹Ý¾ç Á¾¾ç
  • nonclassifed tumor
    ºÐ·ùµÇÁö ¾Ê´Â Á¾¾ç
  • nonodontogenic malignant tumor jaw
    ºñÄ¡¾Æ¼º ¾Ç¼º Á¾¾ç
  • odontogenic mixed tumor
    Ä¡¿ø È¥ÇÕ Á¾¾ç
  • ovarian tumor
    ³­¼Ò Á¾¾ç
    ³­¼Ò¿¡¼­ »ý±â´Â Á¾¾ç. ³­¼Ò´Â ÀÎüÀÇ Àå±â Áß¿¡¼­ °¡Àå ¸¹Àº Á¾·ùÀÇ Á¾¾çÀÌ ¹ß»ýÇÏ´Â ±â°üÀÌ¸ç ±× ºÐ·ù¹ýµµ ´Ù¾çÇØ, ¿©·¯ °¡Áö À̸§À¸·Î ºÒ¸°´Ù. ÀÓ»óÀûÀ¸·Î´Â ¾ç¼º, ¾Ç¼º, Áß°£¼ºÀÇ ¼¼ °¡Áö·Î ´ëº°µÇÁö¸¸ °¨º°ÀÌ °ï¶õÇÑ °æ¿ìµµ ÀÖ´Ù. ´ëü·Î Ãæ½ÇºÎ°¡ ÀüÇô ¾ø´Â ¼ø³¶Æ÷¼ºÀÇ °ÍÀ» ³¶Æ÷¼º Á¾¾çÀ̶ó ÇÏ¸ç ¾ç¼ºÀÌ´Ù. Ãæ½ÇºÎ·Î µÇ¾î ÀÖ´Â °æ¿ì¸¦ Ãæ½Ç¼º Á¾¾çÀ̶ó Çϸç, ³¶Æ÷ºÎ¿Í Ãæ½ÇºÎ°¡ ¼¯¿© ÀÖ´Â °æ¿ì¸¦ ¹ÝÃæ½Ç¼º Á¾¾çÀ̶ó Çϴµ¥ ÀÌ µÎ °¡Áö¸¦ ÇÕÃļ­ Ãæ½Ç¼º Á¾¾çÀ̶ó ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
genes, nef DNA sequences that form the coding region for a protein that down-regulates the expression of human immunodeficiency virus (HIV). Nef is short for negative factor.
(12 Dec 1998)
genes, neurofibromatosis 1 Tumour suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause neurofibromatosis 1.
(12 Dec 1998)
genes, neurofibromatosis 2 Tumour suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes neurofibromatosis 2.
(12 Dec 1998)
genes, nitrogen fixation Regulatory and structural genes present in certain bacteria, algae and fungi that control the conversion of atmospheric nitrogen into biologically usable compounds; include nif structural genes (e.g., nifd, nifh) for nitrogenase and nitrate reductase as well as regulator genes nifa, nifb, ntra, ntrb, ntrc. Some are responsible for regulating transcription of genes involved in the assimilation of poor nitrogen sources in enteric bacteria.
(12 Dec 1998)
genes, overlapping Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells.
(12 Dec 1998)
genes, p16 Tumour suppressor genes located on human chromosome 9 in the region 9p21. This gene is either deleted or mutated in a wide range of malignancies.
(12 Dec 1998)
genes, p53 Tumour suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.
(12 Dec 1998)
genes, plant The hereditary material of plants.
(12 Dec 1998)
genes, pol DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. "pol" is short for polymerase, the enzyme class of reverse transcriptase.
(12 Dec 1998)
genes, protozoan The genetic material of protozoa.
(12 Dec 1998)
genes, px DNA sequences that form the coding region for at least three proteins which regulate the expression of HTLV-I and HTLV-II. The proteins are p21(x), p27(rex), and p40(tax). The tax (trans-activator x) and rex (regulator x) genes are part of px but are in overlapping reading frames. X was the original designation for the sequences or region (at that time of unknown function) in the long open reading frame (lor) which is now called px.
(12 Dec 1998)
genes, rag-1 Genes involved in activating the enzyme vdj recombinase. Rag-1 is located on chromosome 11 in humans (chromosome 2 in mice) and is expressed exclusively in maturing lymphocytes.
(12 Dec 1998)
genes, ras Family of retrovirus-associated DNA sequences (ras) originally isolated from harvey (h-ras, ha-ras, rash) and kirsten (k-ras, ki-ras, rask) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both h-ras and k-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related n-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.
(12 Dec 1998)
genes, recessive Genes that are reflected in the phenotype only in the homozygous state.
(12 Dec 1998)
genes, regulator Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for proteins (repressors or activators) which regulate the genetic transcription of the structural genes and/or regulatory genes.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á